The FDA wants the developers of medical devices that rely on AI to disclose more detail about how their devices were ...

Researchers at Mount Sinai and Memorial Sloan Kettering believe they’ve made a breakthrough in a new form of cancer treatment ...

Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad ...

Jennifer Doudna, a UC Berkeley biochemist who shared the 2020 Nobel Prize in Chemistry for the invention of CRISPR-Cas9 ...

While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...

In its announcement this week of the first human death from bird flu in the United States, health officials in Louisiana were ...

In the PET trial, RAP-219 achieved and exceeded target receptor occupancy, increasing support for the dosing regimen utilized in the ongoing Phase 2a trial in focal epilepsy; restricted ...

Approximately $50.0 million of net revenue from sales of LUMRYZ estimated for the fourth quarter, a greater than 150% increase over $19.5 million for the comparable period in 2023 -- --2,500 patients ...

The evolution of AI, more limited-time product offerings and GLP-1 use for weight loss are among the issues expected to play ...

The government is changing what foods can be branded as “healthy.” It expects basically no one to listen.

These amendments represent the first significant changes to “healthy” labeling requirements in 30 years. In its new scheme, the FDA attempts to bring labeling requirements in line with 21st century ...

By Grace Hussain for Sentient. Broadcast version by Mike Moen for Greater Dakota News Service reporting for the ...